Lombard Odier Asset Management (Usa) Corp Horizon Therapeutics Public LTD CO Transaction History

Lombard Odier Asset Management (Usa) Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $1.03 Million - $1.88 Million	16,500 New	16,500 $1.88 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $1.17 Million - $1.48 Million	-17,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $75,500 - $142,450	2,500 Added 16.67%	17,500 $973,000
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $373,050 - $578,400	15,000 New	15,000 $444,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.